1,024
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation

, , &
Pages 5147-5158 | Received 18 Aug 2020, Accepted 18 Dec 2020, Published online: 31 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gisele Rocha Aguiar, Telma Leda Gomes de Lemos, Raimundo Braz-Filho, Aluísio Marques da Fonseca, Emmanuel Silva Marinho, Paulo Riceli Vasconcelos Ribeiro, Kirley Marques Canuto & Francisco José Queiroz Monte. (2023) Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 41:17, pages 8334-8348.
Read now

Articles from other publishers (3)

Yiwen Huang, Hui Lu, Zhong Li, Yuan Zeng, Qi Xu & Yang Wu. (2023) Development of HPLC-CAD method for simultaneous quantification of nine related substances in ursodeoxycholic acid and identification of two unknown impurities by HPLC-Q-TOF-MS. Journal of Pharmaceutical and Biomedical Analysis 229, pages 115357.
Crossref
Francisco Javier Rodal Canales, Laura Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Luis Manuel Sánchez Navarro, Carlos Alberto Matias-Cervantes, Margarito Martínez Cruz, Eli Cruz Parada, Edgar Zenteno, Edgar Gustavo Ramos-Martínez, Eduardo Pérez-Campos Mayoral, Carlos Romero Díaz & Eduardo Pérez-Campos. (2021) Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis. Scientific Reports 11:1.
Crossref
Mohsen Khosravi. (2021) Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter. Frontiers in Psychiatry 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.